A d-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model

FEMS Microbiology Letters

Volumn 328, Issue 2, 2012, Pages 130-137

  Hayama, Kazumi ^a   Ishibashi, Hiroko ^b   Ishijima, Sanae A ^a   Niimi, Kyoko ^c   Tansho, Shigeru ^d   Ono, Yasuo ^d   Monk, Brian C ^c   Holmes, Ann R ^c   Harding, David R K ^e   Cannon, Richard D ^c   Abe, Shigeru ^a,d  

^a TEIKYO UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e MASSEY UNIVERSITY   (New Zealand)

Author keywords

Antifungal; Candidosis; Chemosensitizer; Drug resistance

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; RC21V3 PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THRUSH;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; FLUCONAZOLE; FUNGAL PROTEINS; ITRACONAZOLE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; OLIGOPEPTIDES; TONGUE;

CANDIDA ALBICANS; MURINAE; MUS;

EID: 84857239454     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2011.02490.x     Document Type: Article

References (25)

1. Blatchford NR (1990) Treatment of oral candidosis with itraconazole: a review. J Am Acad Dermatol 23: 565-567.
2. Cannon RD, Lamping E, Holmes AR, Niimi K, Tanabe K, Niimi M & Monk BC (2007) Candida albicans drug resistance another way to cope with stress. Microbiology 153: 3211-3217.
3. Coste A, Selmecki A, Forche A, Diogo D, Bougnoux ME, d'Enfert C, Berman J & Sanglard D (2007) Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell 6: 1889-1904.
4. de Repentigny L & Ratelle J (1996) Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group. Chemotherapy 42: 374-383.
5. Graybill JR, Montalbo E, Kirkpatrick WR, Luther MF, Revankar SG & Patterson TF (1998) Fluconazole versus Candida albicans: a complex relationship. Antimicrob Agents Chemother 42: 2938-2942.
6. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M & Diekema D (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37: 1172-1177.
7. Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC & Cannon RD (2008) ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother 52: 3851-3862.
8. Ishibashi H, Uchida K, Nishiyama Y, Yamaguchi H & Abe S (2007) Oral administration of itraconazole solution has superior efficacy in experimental oral and oesophageal candidiasis in mice than its intragastric administration. J Antimicrob Chemother 59: 317-320.
9. Kamai Y, Kubota M, Fukuoka T, Kamai Y, Maeda N, Hosokawa T, Shibayama T, Uchida K, Yamaguchi H & Kuwahara S (2003) Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice. Antimicrob Agents Chemother 47: 601-606.
10. Marr KA, Lyons CN, Ha K, Rustad TR & White TC (2001) Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrob Agents Chemother 45: 52-59.
11. Morio F, Loge C, Besse B, Hennequin C & Le Pape P (2010) Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infect Dis 66: 373-384.
12. Naesens M, Kuypers DR & Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4: 481-509.
13. Niimi K, Harding DR, Parshot R et al. (2004) Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob Agents Chemother 48: 1256-1271.
14. Pfaller MA & Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
15. Rex JH, Rinaldi MG & Pfaller MA (1995) Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39: 1-8.
16. Ricardo E, Costa-de-Oliveira S, Dias AS, Guerra J, Rodrigues AG & Pina-Vaz C (2009) Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes. FEMS Yeast Res 9: 618-625.
17. Schuetzer-Muehlbauer M, Willinger B, Egner R, Ecker G & Kuchler K (2003) Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int J Antimicrob Agents 22: 291-300.
18. Slavin MA, Sorrell TC, Marriott D, Thursky KA, Nguyen Q, Ellis DH, Morrissey CO & Chen SC (2010) Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother 65: 1042-1051.
19. Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR & Heitman J (2007) Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 5: 418-430.
20. Sun S, Li Y, Guo Q, Shi C, Yu J & Ma L (2008) In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. Antimicrob Agents Chemother 52: 409-417.
21. Taguchi Y, Hayama K, Okada M, Sagawa T, Arai R & Abe S (2011) Therapeutic effects of cinnamaldehyde and potentiation of its efficacy in combination with methylcellulose on murine oral candidiasis. Med Mycol J 52: 145-152.
22. Takakura N, Sato Y, Ishibashi H, Oshima H, Uchida K, Yamaguchi H & Abe S (2003) A novel murine model of oral candidiasis with local lesions characteristic of oral thrush. Microbiol Immunol 47: 321-326.
23. Tanabe K, Lamping E, Adachi K, Takano Y, Kawabata K, Shizuri Y, Niimi M & Uehara Y (2007) Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium. Biochem Biophys Res Commun 364: 990-995.
24. Uppuluri P, Nett J, Heitman J & Andes D (2008) Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52: 1127-1132.
25. White TC (1997) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41: 1482-1487.